Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.
Also called NCT06360120
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 600 participants
- Sponsor
- Registry
-
NCT06360120
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Recruiting
Technical summary
Registry record NCT06360120. Randomized; double masking; primary purpose treatment. Start 2024-04-10 (actual); primary completion 2025-09-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Atorvastatin 40 Mg Oral Tablet
- Intervention (Drug)
- Rosuvastatin 20mg
- Intervention (Drug)
- Clopidogrel 75 Mg Oral Tablet
- Intervention (Drug)
- Clopidogrel 75 Mg Oral Tablet
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06360120- Content hash
a66bfe4f7008df41c37ec9d35675c7e6868b4054ab1bf39eb63a703fecf2e5cb